Table 1.

Demographic and clinical characteristics of study participants^*

Demographic data	Patients with CID (n = 322)	Control subjects (n = 119)	P
Age, mean ± SD years	48.5 ± 15.7	44.2 ± 15.8	0.01
<65 years, %	80.4	85.9	0.18
65+ years, %	19.6	15.1	–
Female sex, %	71.4	59.9	0.02
White race, %	85.7	73.9	0.01
Vaccine type, %
BNT162b2	73.9	73.1	0.86
mRNA‐1273	26.1	26.9	–
Site, %
WUSTL	65.5	39.5	<0.001
UCSF	35.5	60.5	–

^*CID = chronic inflammatory disease; UCSF = University of California, San Francisco; WUSTL = Washington University in St. Louis.